New PBAC application supports immunotherapy treatment for oesophageal and gastro-oesophageal junction cancers
Pancare is supporting Bristol Meyers Squibb in their application to the Pharmaceutical Benefits Advisory Committee (PBAC) for the funding of Nivolumab, an immunotherapy for the treatment of
Recent study supports use of second line chemotherapy combined with active symptom control (ASC) for the treatment of advanced biliary tract cancer.
Patients with advanced biliary tract cancer receiving second-line FOLFOX chemotherapy and active symptom control (ASC) are more than twice as likely to be alive at 12 months compared to those on ASC
Is there a role for laparoscopic surgery for resection of pancreatic head and neck cancers in Australia?
This recent trial compared 300 patients undergoing laparoscopic vs. 300 patients undergoing open pancreas cancer surgery. Results showed that patients treated with keyhole surgery went home 1 day
New study examines different approaches for selective internal radiation therapy (SIRT) for advanced liver cancer
This recent phase 2 trial examined the effects of personalised dositometry versus standard dositometry of selective internal radiation therapy (SIRT) for treatment of unresectable locally-advanced